{"pub": "marketwatch", "url": "https://marketwatch.com/story/livongos-stock-gains-after-wider-than-expected-loss-but-revenue-rose-above-forecasts-2019-09-05", "downloaded_at": "2019-09-05 11:26:24.372737+00:00", "title": "Livongo's stock gains after wider-than-expected loss, but revenue rose above forecasts", "language": "en", "text": "Shares of Livongo Health Inc. LVGO, +2.18% rose 1% in premarket trading Thursday, after the digital health company reported its first quarterly results since going public, with a wider-than-expected loss but revenue that rose above forecasts. The net loss widened to $14.3 million, or 76 cents a share, from $6.2 million, or 38 cents a share, in the year-ago period. Excluding non-recurring items, the adjusted loss per share was 46 cents, compared with the FactSet per-share loss consensus of 15 cents. Revenue rose 156% to $40.9 million, above the FactSet consensus of $39.7 million. Enrollment for Diabetes Members grew 140% to 192,934, while clients increased 92% to 720. For the third quarter, Livongo expects revenue of $42 million to $43 million, surrounding the FactSet consensus of $42.3 million. The stock has lost 19% since it closed at $38.10 on its first day of trading on July 25, while the S&P 500 SPX, +1.08% has declined 2.2% over the same time.", "description": "Shares of Livongo Health Inc. rose 1% in premarket trading Thursday, after the digital health company reported its first quarterly results since going...", "authors": ["Tomi Kilgore", "Reporter"], "top_image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "published_at": "2019-09-05"}